No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
149 |
4. Check minimum number of eventsNone |
149 |
5. Include endpointsNone |
149 |
6. Filter based on genotype QC (FinnGen only) |
149 |
Control definitions (FinnGen only)
- Control exclude
- F5_PERSOBEH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F60-F62
- Name in latin
- Commutationes personalitatis persistentes non laesioni neque morbo cerebri ascribendae
Similar endpoints
↥List of similar endpoints to
Enduring personality changes
based on the number of shared cases.
Similar with more cases:
- Disorders of adult personality and behaviour
- Any mental disorder
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1229 | 593 | 625 |
| Only index persons | 1114 | 557 | 557 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 43.28 | 42.70 | 43.81 |
| Only index persons | 42.94 | 42.65 | 43.22 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 149 | 81 | 68 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 44.93 | 42.45 | 47.89 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 140
- Matched controls
- 1399
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F62.9
ICD-10 Finland
Enduring personality change, unspecified
+∞
57.3
51
*
F62.0
ICD-10 Finland
Enduring personality change after catastrophic experience
+∞
45.3
41
*
N05AH04
ATC
quetiapine; oral
15.0
40.5
78
108
F62.8
ICD-10 Finland
Other enduring personality changes
+∞
36.0
33
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
20.4
33.0
51
38
F32.9
ICD-10 Finland
Depressive episode, unspecified
13.0
33.0
65
87
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
17.3
29.8
49
42
N05AX08
ATC
risperidone; systemic
16.7
28.2
47
41
N05AH03
ATC
olanzapine; systemic
22.4
25.3
37
22
N06AB04
ATC
citalopram; systemic
8.1
24.8
67
143
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
+∞
24.7
23
*
N06AX16
ATC
venlafaxine; oral
8.7
24.3
60
111
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
15.4
22.5
38
33
N06AX11
ATC
mirtazapine; oral
6.0
21.7
84
279
N05AX12
ATC
aripiprazole; systemic
23.0
21.6
31
17
N05AA02
ATC
levomepromazine; systemic
24.0
20.6
29
15
T36
ICD-10 Finland
Poisoning by systemic antibiotics
19.5
20.5
31
20
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
10.7
20.2
41
52
F60.9
ICD-10 Finland
Personality disorder, unspecified
81.6
19.3
21
*
F62.1
ICD-10 Finland
Enduring personality change after psychiatric illness
+∞
19.2
18
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
8.8
18.0
41
63
N05AB03
ATC
perphenazine; systemic, rectal
23.1
17.6
25
13
N05BA01
ATC
diazepam; systemic, rectal
7.9
17.5
43
74
N05CD07
ATC
temazepam; oral
8.6
17.4
40
62
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
21.4
17.2
25
14
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
+∞
17.0
16
*
F61.0
ICD-10 Finland
Mixed personality disorders
+∞
17.0
16
*
N06AB03
ATC
fluoxetine; oral
7.3
16.8
44
83
N05BA04
ATC
oxazepam; oral
5.3
16.8
62
181
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
7.9
16.5
40
67
N06AB06
ATC
sertraline; oral
7.6
16.0
40
70
N05AF03
ATC
chlorprothixene; systemic
27.2
15.6
21
9
F29
ICD-10 Finland
Unspecified nonorganic psychosis
15.8
14.9
24
18
N03AG01
ATC
valproic acid; systemic, rectal
11.4
14.8
28
30
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
13.0
14.8
26
24
N05CF01
ATC
zopiclone; oral
4.3
13.9
67
246
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
154.3
13.7
14
*
P29
ICPC
Psychological sympt/compl other
10.2
13.5
27
32
N06AX03
ATC
mianserin; oral
15.1
13.5
22
17
N06AA09
ATC
amitriptyline; systemic
8.2
13.1
30
45
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
17.7
13.1
20
13
N03AX09
ATC
lamotrigine; oral
10.6
12.9
25
28
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
8.4
11.7
26
37
N03AE01
ATC
clonazepam; systemic
9.4
11.7
24
30
F34.1
ICD-10 Finland
Dysthymia
12.7
11.5
20
18
ZY010
NOMESCO Finland
Hospital outpatient
9.1
11.5
24
31
N03AX16
ATC
pregabalin; oral
4.3
11.4
48
151
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
5.9
11.4
33
69
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
19.8
11.0
16
9
N06AX21
ATC
duloxetine; oral
5.8
10.9
32
68
N03AX12
ATC
gabapentin; oral
4.8
10.9
39
104
F43.1
ICD-10 Finland
Post-traumatic stress disorder
15.9
10.8
17
12
F60.5
ICD-10 Finland
Anankastic personality disorder
118.5
10.6
11
*
F20.9
ICD-10 Finland
Schizophrenia, unspecified
25.7
10.5
14
6
P76
ICPC
Depressive disorder
7.4
10.5
25
40
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
16.2
10.3
16
11
N05BA06
ATC
lorazepam; systemic, sublingual
10.8
10.1
19
20
N04AA02
ATC
biperiden; systemic
43.4
10.1
12
*
N05BE01
ATC
buspirone; oral
22.0
10.0
14
7
IGY99
NOMESCO Finland
Other psychiatric treatment contact
22.0
10.0
14
7
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
23.7
9.5
13
6
Z2446
NOMESCO Finland
Social worker
6.2
9.3
25
47
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
17.1
9.2
14
9
N05AD01
ATC
haloperidol; systemic
17.1
9.2
14
9
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
9.7
9.1
18
21
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
20.3
9.1
13
7
N05BA12
ATC
alprazolam; oral
5.1
9.0
29
68
N06AB05
ATC
paroxetine; oral
7.9
8.9
20
29
N06AA12
ATC
doxepin; systemic
9.2
8.9
18
22
F32.1
ICD-10 Finland
Moderate depressive episode
6.1
8.8
24
46
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
6.1
8.8
24
46
F40.1
ICD-10 Finland
Social phobias
17.7
8.7
13
8
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
8.8
8.7
18
23
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
29.6
8.6
11
*
F61
ICD-10 Finland
Mixed and other personality disorders
+∞
8.4
8
*
A01
ICPC
Pain general/multiple sites
6.7
8.4
21
36
N06AG02
ATC
moclobemide; oral
9.4
8.1
16
19
N03AF01
ATC
carbamazepine; oral, rectal
9.4
8.1
16
19
IGY02
NOMESCO Finland
Psychiatric monitoring contact
14.2
8.1
13
10
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
5.6
8.0
23
47
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
5.4
7.8
23
49
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
19.7
7.7
11
6
F32.8
ICD-10 Finland
Other depressive episodes
19.7
7.7
11
6
A06AD11
ATC
lactulose; oral
4.9
7.7
25
59
SPAT1240
SPAT
Therapeutic discussion
4.0
7.7
32
97
R51.80
ICD-10 Finland
Headache
3.8
7.7
34
109
SPAT1260
SPAT
Consultation of another employee
3.6
7.6
36
122
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.4
7.6
40
146
R52.2
ICD-10 Finland
Other chronic pain
14.4
7.5
12
9
F41.1
ICD-10 Finland
Generalized anxiety disorder
6.3
7.4
19
34
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
6.3
7.4
19
34
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
+∞
7.3
7
*
F60.8
ICD-10 Finland
Other specific personality disorders
+∞
7.3
7
*
F51.0
ICD-10 Finland
Nonorganic insomnia
3.8
7.3
32
101
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.0
7.3
23
53
N05AN01
ATC
lithium; oral
13.0
7.2
12
10
L03
ICPC
Low back symptom/complaint
3.1
7.2
45
186
F99
ICD-10 Finland
Mental disorder, not otherwise specified
14.8
7.0
11
8
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
10.1
7.0
13
14
N05AL01
ATC
sulpiride; systemic
23.9
6.8
9
*
N05CF02
ATC
zolpidem; oral
3.3
6.7
36
132
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
10.8
6.7
12
12
P72
ICPC
Schizophrenia
15.2
6.5
10
7
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
15.2
6.5
10
7
3074A
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]
73.0
6.5
7
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
11.8
6.4
11
10
P99
ICPC
Psychological disorders other
11.8
6.4
11
10
L28
ICPC
Limited function/disability (L)
3.9
6.4
26
77
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
19.1
6.3
9
5
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
19.1
6.3
9
5
M54.4
ICD-10 Finland
Lumbago with sciatica
3.3
6.3
32
114
F60.2
ICD-10 Finland
Dissocial personality disorder
+∞
6.3
6
*
M54.5
ICD-10 Finland
Low back pain
2.6
6.3
60
317
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
13.3
6.2
10
8
N06CA01
ATC
amitriptyline and psycholeptics; systemic
4.1
6.1
23
64
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028707) Methadone [Presence] in Urine by Screen method
26
28
11.04
22.43
2.3
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
24
40
6.96
14.36
4.0
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
26
53
5.73
12.70
2.6
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
26
63
4.79
10.39
3.2
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
26
66
4.56
9.80
3.3
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
26
67
4.49
9.61
3.2
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
26
67
4.49
9.61
3.3
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
25
68
4.22
8.60
3.4
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
62
310
2.71
7.87
3.5
3.0
mmol/l
7.2
8.3
0.81
50
269
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
71
388
2.59
7.43
2.0
1.8
pmol/l
99.7
97.1
0.18
45
206
(3016502) Oxygen saturation in Arterial blood
28
92
3.52
7.35
12.0
12.5
%
93.4
96.5
0.67
28
87
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
21
61
3.84
6.56
1.4
1.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
28
101
3.18
6.32
12.0
11.5
kpa
5.5
5.2
0.93
28
95
(3027801) Oxygen [Partial pressure] in Arterial blood
28
101
3.18
6.32
12.0
11.5
kpa
10.6
13.1
1.89
28
96
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
74
437
2.38
6.28
7.5
6.9
mmol/l
1.2
1.2
0.59
69
410
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
78
474
2.35
6.17
7.9
7.6
mmol/l
1.2
1.2
0.33
70
405
(3019150) Specific gravity of Urine by Refractometry
51
257
2.50
6.13
4.4
3.6
kg/l
1.0
1.0
—
9
32
(3002173) Hemoglobin [Mass/volume] in Arterial blood
24
85
3.17
5.56
11.5
13.4
g/l
120.0
125.5
0.66
24
80
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
45
230
2.37
5.13
2.3
1.9
mg/l
2.9
2.9
0.02
38
198
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
27
110
2.78
4.89
1.7
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34
156
2.53
4.88
1.7
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
27
111
2.75
4.80
1.7
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
17
53
3.49
4.78
2.3
2.9
mmol/l
1.5
1.2
—
8
44
(3015377) Calcium [Moles/volume] in Serum or Plasma
60
358
2.13
4.65
2.0
3.3
mmol/l
2.3
2.4
0.27
54
319
(3000991) Gas panel - Venous blood
22
83
2.94
4.56
12.7
7.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
114
875
2.29
4.47
7.3
7.4
u/l
83.5
75.3
0.89
107
826
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
9
12
7.90
4.42
14.3
9.6
mmol/l
0.8
0.6
—
9
12
(3026008) Bacteria identified in Urine by Culture
49
278
2.14
4.26
4.3
2.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
19
70
2.96
4.10
2.4
3.2
e9/l
66.4
72.1
0.40
14
51
(21494755) Public health laboratory ask at order entry panel
5
201
0.22
4.08
1.4
1.3
—
—
—
0
0
(4198724)
7
7
10.41
4.05
1.3
1.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
86
611
1.96
3.92
6.1
6.3
e9/l
2.0
1.9
0.67
75
549
(3006315) Basophils [#/volume] in Blood
83
588
1.93
3.76
6.4
6.4
e9/l
0.0
0.0
0.41
72
522
(3032080) INR in Blood by Coagulation assay
61
390
1.96
3.76
14.6
7.8
inr
1.2
1.1
0.42
22
118
(3013115) Eosinophils [#/volume] in Blood
85
608
1.93
3.73
7.1
6.8
e9/l
0.2
0.2
0.18
75
546
(3019060) Gas panel - Arterial blood
17
62
2.97
3.73
5.0
11.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
35
3.64
3.70
1.4
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
67
444
1.92
3.70
4.4
5.1
g/l
36.0
36.8
0.56
62
425
(3012516) Albumin [Mass/volume] in Urine
47
276
2.03
3.67
3.1
3.2
mg/l
1944.4
316.6
0.39
26
177
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
114
906
2.10
3.63
6.1
3.8
pmol/l
14.3
14.5
0.37
109
840
(3001604) Monocytes [#/volume] in Blood
82
588
1.88
3.50
6.3
6.3
e9/l
0.6
0.6
0.67
73
523
(3020682) Albumin/Creatinine [Ratio] in Urine
48
290
1.97
3.43
3.6
4.0
mg/mmol
1.2
8.4
3.40
29
184
(3023368) Bacteria identified in Blood by Culture
44
259
1.99
3.38
4.6
4.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
33
176
2.12
3.30
1.9
2.9
mmol/l
2.5
2.4
0.74
27
152
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
34
184
2.10
3.27
2.8
1.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
32
173
2.08
3.08
2.0
2.5
e6/l
4.3
2.2
0.66
13
97
(3012544) pH of Venous blood
21
96
2.38
3.00
3.1
4.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
12
41
3.10
2.93
1.9
2.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
57
381
1.80
2.92
5.0
6.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
79
582
1.76
2.90
5.6
6.1
%
29.8
29.0
0.26
74
555
(3018010) Neutrophils/100 leukocytes in Blood
78
573
1.76
2.89
5.3
6.0
%
55.6
56.3
0.21
72
548
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
35
202
1.96
2.81
3.0
2.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
42
259
1.87
2.77
2.5
1.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
10
6.20
2.72
3.0
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
45
287
1.81
2.66
3.5
4.1
ph
7.4
7.4
—
7
58
(3015736) pH of Urine
66
472
1.72
2.62
4.6
3.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
41
258
1.81
2.52
3.8
3.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
39
242
1.83
2.50
1.9
1.8
mg/l
0.7
0.9
0.31
30
182
(3042936) Bacteria identified in Isolate by Culture
27
149
1.99
2.45
2.1
2.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
57
399
1.69
2.41
3.8
2.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
151
0.31
2.31
1.4
1.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
77
588
1.64
2.30
6.1
6.5
umol/l
8.8
10.9
2.57
70
567
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
20
101
2.13
2.28
2.6
2.7
u/l
49.6
28.7
0.31
13
84
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
18
4.03
2.28
1.4
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
42
2.75
2.24
13.8
21.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
70
526
1.62
2.21
3.5
2.6
ug/l
88.1
98.7
0.19
65
495
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
130
1152
2.01
2.15
5.4
3.9
mmol/l
6.0
5.8
0.53
124
1081
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
10
5.13
2.08
1.0
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
98
808
1.62
2.05
4.3
3.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
50
351
1.64
2.04
3.1
2.8
e6/l
19.4
50.2
0.87
38
272
(3035350) Ketones [Presence] in Urine by Test strip
76
591
1.58
2.03
4.1
3.3
estimate
0.0
0.0
0.00
15
112
(3013826) Glucose [Moles/volume] in Serum or Plasma
81
641
1.58
2.00
8.4
5.1
mmol/l
6.7
6.5
0.30
76
589
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
124
1092
1.81
1.96
6.7
4.7
mmol/mol
38.6
38.6
0.04
119
1036
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
17
86
2.10
1.94
4.0
2.4
ml/min/173m2
90.8
73.3
—
5
36
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
30
186
1.77
1.91
2.1
2.3
e6/l
0.9
1.0
0.08
12
109
(3029937) Albumin [Presence] in Urine by Test strip
44
305
1.63
1.87
4.2
3.6
estimate
0.0
0.0
0.00
15
113
(3044941) Cell count panel - Synovial fluid
5
12
4.27
1.84
2.0
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
75
591
1.54
1.83
5.8
4.6
estimate
0.0
0.0
0.00
15
113
(3007853) Bacteria identified in Skin by Aerobe culture
23
133
1.86
1.83
2.1
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
85
689
1.54
1.82
9.1
9.8
e9/l
4.2
3.9
0.59
76
606
(3028626) Oxygen [Partial pressure] in Capillary blood
7
23
3.14
1.82
1.1
3.0
kpa
8.8
8.8
—
7
23
(3017143) Hepatitis C virus Ab [Presence] in Serum
25
149
1.81
1.81
2.0
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
125
1113
1.76
1.77
6.9
4.3
mu/l
1.8
1.9
0.43
119
1030
(3036489) Thrombin time
9
36
2.59
1.77
1.2
3.1
s
21.7
20.5
—
9
31
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
18
3.43
1.76
1.2
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
29
183
1.73
1.74
3.3
2.9
ng/l
39.9
128.2
0.95
20
123
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
38
261
1.61
1.66
3.3
2.9
ng/l
651.1
815.4
0.34
33
219
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
54
403
1.53
1.66
4.8
3.3
ng/l
15.1
53.4
1.72
35
233
(3030467) Casts [#/volume] in Urine by Automated count
44
314
1.57
1.64
3.2
2.6
e6/l
0.5
0.3
0.25
32
232
(3009261) Glucose [Presence] in Urine by Test strip
75
601
1.50
1.64
4.2
3.4
estimate
0.0
0.0
0.00
14
108
(3021901) Oxygen saturation in Capillary blood
5
14
3.66
1.63
1.2
3.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
32
2.58
1.62
1.9
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
26
2.77
1.60
1.0
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
12
58
2.16
1.54
3.2
3.0
%
0.8
0.7
0.75
12
58
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
15
3.41
1.53
4.8
2.5
u/ml
3.3
2.1
—
5
15
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
18
102
1.87
1.53
2.4
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
21
2.93
1.52
1.0
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
66
522
1.47
1.51
10.4
9.2
e9/l
0.0
0.0
0.50
53
421
(40758558) Short blood count panel - Blood
40
285
1.55
1.50
6.1
6.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
31
208
1.62
1.49
1.7
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
103
893
1.50
1.45
4.3
3.8
mm/h
11.3
9.1
0.88
98
840
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
12
60
2.09
1.42
3.2
2.9
%
2.2
1.0
0.85
12
60
(3021879) Hepatitis B virus core Ab [Presence] in Serum
16
90
1.87
1.39
1.8
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
21
129
1.73
1.39
1.3
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
23
2.67
1.38
1.2
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
53
408
1.46
1.37
4.0
3.2
e6/l
83.5
37.8
0.41
37
290
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
11
54
2.12
1.36
2.0
1.7
u/l
—
3664.8
—
0
16
(3039443) Prostate specific Ag panel - Serum or Plasma
0
37
0.00
1.36
0.0
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
24
155
1.65
1.33
1.4
1.3
—
—
—
0
0
(3020891) Body temperature
9
43
2.16
1.33
8.8
4.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
34
2.43
1.31
1.3
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
18
2.84
1.29
1.0
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
36
259
1.51
1.28
1.9
2.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
14
78
1.88
1.26
3.4
1.7
g/l
0.9
1.5
0.88
14
71
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
19
2.69
1.22
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
38
2.17
1.20
1.1
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
26
2.36
1.20
1.3
3.9
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
13
72
1.88
1.19
2.0
1.7
iu/l
23.3
26.1
—
7
63
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
81
930
0.72
1.18
3.3
3.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
109
1190
0.69
1.16
18.2
12.1
%
40.3
40.9
0.40
77
971
(1761868) Lipid panel - Serum or Plasma
40
515
0.69
1.15
2.7
2.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
14
81
1.80
1.13
2.5
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
16
98
1.71
1.08
3.6
2.4
g/l
11.3
10.2
0.52
16
86
(3044290) Cell count panel - Cerebral spinal fluid
7
33
2.18
1.07
1.0
1.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
45
353
1.39
1.02
2.0
2.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
7
35
2.05
1.01
2.6
16.8
%
2.1
1.6
—
7
30
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
54
1.91
0.99
1.4
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
10
54
1.91
0.99
1.4
2.7
—
—
—
0
0
(3044889) 12 lead EKG panel
90
791
1.35
0.98
3.5
3.4
—
—
—
0
0
(4034850)
7
37
1.93
0.95
11.6
8.8
—
—
—
0
0
(3013512) EKG study
36
276
1.40
0.93
4.8
3.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
40
318
1.35
0.83
3.3
2.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
37
292
1.36
0.80
7.5
5.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
10
59
1.74
0.78
8.6
6.8
mmol/l
25.9
24.8
—
10
59
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
39
1.83
0.73
1.6
2.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
56
476
1.28
0.72
4.7
3.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
5
26
1.95
0.71
1.6
3.8
%
193.2
178.0
—
5
26
(3048929) Epstein Barr virus Ab [Presence] in Serum
7
43
1.66
0.68
1.4
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
70
1.62
0.67
1.5
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
28
352
0.75
0.66
1.4
1.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
44
1.62
0.66
1.1
1.0
—
—
—
0
0
(3019225) pH of Specimen
12
79
1.56
0.65
2.6
4.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
29
1.75
0.64
5.2
4.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
46
387
1.27
0.63
3.6
4.1
ug/l
1.1
1.7
1.98
41
346
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
5
30
1.69
0.62
1.4
3.5
%
91.0
94.6
—
5
30
(3007164) IgA [Mass/volume] in Serum or Plasma
33
267
1.30
0.61
2.2
1.4
g/l
2.3
2.3
0.04
20
169
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
53
1.54
0.59
1.1
1.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
8
53
1.54
0.59
2.3
1.8
nmol/l
39.9
36.4
—
8
53
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
35
1.74
0.58
1.2
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
34
279
1.28
0.57
1.4
1.3
u/ml
0.5
1.6
—
8
85
(36660697) Celiac disease serology panel - Serum
14
100
1.44
0.54
1.2
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
107
1133
0.80
0.53
23.7
14.6
g/l
332.9
333.6
0.29
107
1124
(3019832) Treponema pallidum Ab [Presence] in Serum
19
146
1.35
0.50
2.3
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
129
1238
1.31
0.48
17.2
11.6
mg/l
23.4
21.0
0.31
105
926
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
47
1.51
0.48
2.3
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
10
68
1.50
0.48
1.0
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
16
208
0.74
0.48
1.3
1.3
u/ml
1.5
7.7
—
6
87
(40761535) Cells panel - Urine sediment
11
78
1.44
0.44
7.6
3.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
92
0.64
0.44
2.0
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
120
1146
1.24
0.44
15.7
10.5
ml/min/173m2
92.2
88.2
1.19
98
929
(4010399)
12
87
1.41
0.44
1.6
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
31
1.63
0.43
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
31
1.63
0.43
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
32
1.58
0.42
1.0
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
32
1.58
0.42
1.2
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
34
290
1.22
0.42
1.3
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(4094501)
5
35
1.44
0.39
1.2
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
3.2
—
17.6
—
0
19
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
79
0.62
0.36
1.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
96
911
1.15
0.31
5.3
3.0
u/l
46.4
45.0
0.07
91
880
(3000492) Spirometry study
11
139
0.77
0.28
1.1
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
12
149
0.79
0.27
1.5
1.2
—
—
—
0
0
(1002224) Polysomnography panel
5
72
0.68
0.26
1.2
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
14
169
0.81
0.25
1.2
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7
94
0.73
0.23
2.6
2.2
—
19.8
—
0
5
(3045414) Leukocytes [Presence] in Urine
5
40
1.26
0.22
1.2
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.1
—
782.2
—
0
11
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
11
0.00
0.21
0.0
4.8
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(4281824)
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
1.0
—
0
10
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
39
357
1.13
0.21
3.8
3.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
13
0.00
0.21
0.0
3.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
14
0.00
0.20
0.0
2.0
—
13.6
—
0
14
(40768795) Lymph node Pathology biopsy report
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
4.2
—
88.2
—
0
14
(3022145) Colonoscopy Study observation
10
120
0.82
0.17
1.1
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
83
1.22
0.16
1.7
2.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
14
121
1.17
0.15
14.6
7.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
79
1.15
0.15
1.1
1.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
10
84
1.20
0.14
2.0
1.2
u/ml
85.1
187.3
—
10
76
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
57
546
1.07
0.12
3.5
4.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
47
1.07
0.09
1.6
3.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
48
1.04
0.09
1.2
2.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
53
1.14
0.09
5.3
3.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
75
1.07
0.07
1.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
8
78
1.03
0.07
1.3
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
30
309
0.96
0.02
3.7
4.0
%
17.7
21.8
0.92
11
123
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
22
228
0.96
0.02
2.1
2.4
ug/l
0.5
0.7
1.70
17
125
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
23
238
0.96
0.02
1.6
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
139
1397
0.93
0.02
26.9
17.3
g/l
137.1
137.9
0.31
139
1381
(3024731) MCV [Entitic volume]
139
1396
0.94
0.01
26.4
17.2
fl
90.8
90.6
0.20
139
1380
(3026361) Erythrocytes [#/volume] in Blood
139
1396
0.94
0.01
26.4
17.3
e12/l
4.6
4.6
0.02
134
1365
(3010813) Leukocytes [#/volume] in Blood
139
1396
0.94
0.01
26.5
17.3
e9/l
7.0
6.5
2.10
134
1364
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
22
214
1.03
0.00
1.3
1.3
iu/ml
173.9
26.7
—
5
74
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
13
126
1.03
0.00
1.2
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
130
1304
0.98
0.00
16.4
10.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
139
1393
0.97
0.00
26.5
17.3
e9/l
264.0
251.7
1.59
134
1364
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
11
107
1.03
0.00
5.9
2.9
—
—
—
0
0
(3035941) MCH [Entitic mass]
139
1395
0.95
0.00
26.4
17.2
pg
30.2
30.3
0.30
139
1378
(40768804) Tissue Pathology biopsy report
48
476
1.01
0.00
1.9
1.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
54
0.92
0.00
1.2
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
8
0.00
0.00
0.0
4.8
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
10
100
1.00
0.00
3.9
3.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.7
—
10.5
—
0
6
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.0
—
5.8
—
0
6
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
95.0
—
0
6
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4024509)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
0.7
—
0
5
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
131.8
—
0
5
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(4211845)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
162.0
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint F5_PERSOCHANGE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_PERSOCHANGE | 3.327 [2.45, 4.53] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.089 |
During the follow-up period (1.1.1998 — 31.12.2019), 74 out of 515 females with F5_PERSOCHANGE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_PERSOCHANGE | 2.806 [2.0, 3.94] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.016 |
During the follow-up period (1.1.1998 — 31.12.2019), 114 out of 545 males with F5_PERSOCHANGE died.
Mortality risk
Mortality risk for people of age
years, who have F5_PERSOCHANGE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.292% | 0.583% |
| 5 | 1.694% | 3.167% |
| 10 | 4.18% | 7.849% |
| 15 | 7.833% | 15.454% |
| 20 | 14.019% | 26.046% |
Relationships between endpoints
↥Index endpoint: F5_PERSOCHANGE – Enduring personality changes
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data